This company has been marked as potentially delisted and may not be actively trading. Cytori Therapeutics (CYTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CYTX vs. CRIS, SABS, BOLT, MTEM, AMGN, GILD, VRTX, REGN, ALNY, and BIIBShould you be buying Cytori Therapeutics stock or one of its competitors? The main competitors of Cytori Therapeutics include Curis (CRIS), SAB Biotherapeutics (SABS), Bolt Biotherapeutics (BOLT), Molecular Templates (MTEM), Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Alnylam Pharmaceuticals (ALNY), and Biogen (BIIB). These companies are all part of the "biotechnology" industry. Cytori Therapeutics vs. Its Competitors Curis SAB Biotherapeutics Bolt Biotherapeutics Molecular Templates Amgen Gilead Sciences Vertex Pharmaceuticals Regeneron Pharmaceuticals Alnylam Pharmaceuticals Biogen Cytori Therapeutics (NASDAQ:CYTX) and Curis (NASDAQ:CRIS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Which has more volatility and risk, CYTX or CRIS? Cytori Therapeutics has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Comparatively, Curis has a beta of 3.6, suggesting that its share price is 260% more volatile than the S&P 500. Which has better valuation & earnings, CYTX or CRIS? Cytori Therapeutics has higher earnings, but lower revenue than Curis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytori Therapeutics$3.67M1.79-$12.63MN/AN/ACuris$10.91M1.76-$43.39M-$6.23-0.30 Is CYTX or CRIS more profitable? Cytori Therapeutics has a net margin of -242.60% compared to Curis' net margin of -376.08%. Curis' return on equity of 0.00% beat Cytori Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cytori Therapeutics-242.60% -272.70% -56.23% Curis -376.08%N/A -97.14% Do insiders and institutionals believe in CYTX or CRIS? 2.6% of Cytori Therapeutics shares are owned by institutional investors. Comparatively, 30.0% of Curis shares are owned by institutional investors. 0.7% of Cytori Therapeutics shares are owned by company insiders. Comparatively, 5.5% of Curis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer CYTX or CRIS? In the previous week, Curis had 3 more articles in the media than Cytori Therapeutics. MarketBeat recorded 3 mentions for Curis and 0 mentions for Cytori Therapeutics. Cytori Therapeutics' average media sentiment score of 0.00 equaled Curis'average media sentiment score. Company Overall Sentiment Cytori Therapeutics Neutral Curis Neutral Do analysts prefer CYTX or CRIS? Curis has a consensus price target of $17.00, indicating a potential upside of 823.91%. Given Curis' stronger consensus rating and higher possible upside, analysts clearly believe Curis is more favorable than Cytori Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytori Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Curis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCuris beats Cytori Therapeutics on 9 of the 13 factors compared between the two stocks. Get Cytori Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTX vs. The Competition Export to ExcelMetricCytori TherapeuticsSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.57M$247.78M$5.53B$8.95BDividend YieldN/AN/A5.38%4.09%P/E RatioN/A5.9227.4020.24Price / Sales1.7970.58417.66125.07Price / CashN/A196.1236.6357.47Price / Book0.856.138.085.67Net Income-$12.63M-$26.71M$3.16B$248.47M Cytori Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTXCytori TherapeuticsN/A$0.30-3.5%N/A-79.9%$6.57M$3.67M0.0037High Trading VolumeCRISCuris2.3958 of 5 stars$2.15-7.3%$17.00+690.7%-70.6%$24.27M$10.91M-0.3560News CoverageSABSSAB Biotherapeutics3.5997 of 5 stars$1.76+0.3%$13.25+652.8%-41.0%$16.30M$1.32M-0.48140BOLTBolt Biotherapeutics3.0493 of 5 stars$6.00+4.0%$50.00+733.3%-58.5%$11.06M$7.69M-0.1890News CoveragePositive NewsHigh Trading VolumeMTEMMolecular TemplatesN/AN/AN/AN/A$1K$23.48M0.00260AMGNAmgen4.5262 of 5 stars$290.52+4.1%$307.82+6.0%-3.6%$150.13B$33.42B26.5128,000Positive NewsGILDGilead Sciences4.8471 of 5 stars$111.73+0.8%$110.55-1.1%+67.1%$137.91B$28.75B23.5217,600Positive NewsInsider TradeVRTXVertex Pharmaceuticals4.7287 of 5 stars$452.16+1.6%$511.62+13.2%-3.3%$114.33B$11.02B-115.356,100Positive NewsREGNRegeneron Pharmaceuticals4.9415 of 5 stars$534.91+1.9%$813.57+52.1%-46.8%$56.68B$14.20B13.6215,106Trending NewsALNYAlnylam Pharmaceuticals4.3159 of 5 stars$322.06-1.2%$340.00+5.6%+33.5%$42.52B$2.25B-154.102,230BIIBBiogen4.9475 of 5 stars$130.07+3.6%$188.48+44.9%-41.0%$18.40B$9.68B12.847,605 Related Companies and Tools Related Companies CRIS Competitors SABS Competitors BOLT Competitors MTEM Competitors AMGN Competitors GILD Competitors VRTX Competitors REGN Competitors ALNY Competitors BIIB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytori Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytori Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTX Stock Alerts